These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16971039)

  • 1. Larger numbers of silenced genes in cancer cell lines with increased de novo methylation of scattered CpG sites.
    Moriguchi K; Yamashita S; Tsujino Y; Tatematsu M; Ushijima T
    Cancer Lett; 2007 May; 249(2):178-87. PubMed ID: 16971039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
    Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
    Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer.
    Takada H; Wakabayashi N; Dohi O; Yasui K; Sakakura C; Mitsufuji S; Taniwaki M; Yoshikawa T
    Cancer Genet Cytogenet; 2010 Feb; 197(1):16-24. PubMed ID: 20113832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of 27 5' CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers.
    Hagihara A; Miyamoto K; Furuta J; Hiraoka N; Wakazono K; Seki S; Fukushima S; Tsao MS; Sugimura T; Ushijima T
    Oncogene; 2004 Nov; 23(53):8705-10. PubMed ID: 15467763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation.
    Takada H; Imoto I; Tsuda H; Nakanishi Y; Ichikura T; Mochizuki H; Mitsufuji S; Hosoda F; Hirohashi S; Ohki M; Inazawa J
    Oncogene; 2005 Dec; 24(54):8051-60. PubMed ID: 16103878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional epigenomics identifies genes frequently silenced in prostate cancer.
    Lodygin D; Epanchintsev A; Menssen A; Diebold J; Hermeking H
    Cancer Res; 2005 May; 65(10):4218-27. PubMed ID: 15899813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased fidelity in replicating CpG methylation patterns in cancer cells.
    Ushijima T; Watanabe N; Shimizu K; Miyamoto K; Sugimura T; Kaneda A
    Cancer Res; 2005 Jan; 65(1):11-7. PubMed ID: 15665274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
    Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification.
    Misawa A; Inoue J; Sugino Y; Hosoi H; Sugimoto T; Hosoda F; Ohki M; Imoto I; Inazawa J
    Cancer Res; 2005 Nov; 65(22):10233-42. PubMed ID: 16288011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterned CpG methylation of silenced B cell gene promoters in classical Hodgkin lymphoma-derived and primary effusion lymphoma cell lines.
    Doerr JR; Malone CS; Fike FM; Gordon MS; Soghomonian SV; Thomas RK; Tao Q; Murray PG; Diehl V; Teitell MA; Wall R
    J Mol Biol; 2005 Jul; 350(4):631-40. PubMed ID: 15967459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
    Shin SH; Park SY; Kang GH
    Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.
    Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C
    Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide analysis in a murine Dnmt1 knockdown model identifies epigenetically silenced genes in primary human pituitary tumors.
    Dudley KJ; Revill K; Whitby P; Clayton RN; Farrell WE
    Mol Cancer Res; 2008 Oct; 6(10):1567-74. PubMed ID: 18922972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer.
    Zhang Z; Huettner PC; Nguyen L; Bidder M; Funk MC; Li J; Rader JS
    Oncogene; 2006 Aug; 25(39):5436-45. PubMed ID: 16607278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
    Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
    Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenomatous polyposis coli 1A is likely to be methylated as a passenger in human gastric carcinogenesis.
    Hosoya K; Yamashita S; Ando T; Nakajima T; Itoh F; Ushijima T
    Cancer Lett; 2009 Nov; 285(2):182-9. PubMed ID: 19527921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of RUNX3 methylation in neoplastic and non-neoplastic gastric epithelia using a DNA microarray.
    So K; Tamura G; Honda T; Homma N; Endoh M; Togawa N; Nishizuka S; Motoyama T
    Pathol Int; 2006 Oct; 56(10):571-5. PubMed ID: 16984612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing.
    Hamada T; Goto M; Tsutsumida H; Nomoto M; Higashi M; Sugai T; Nakamura S; Yonezawa S
    Cancer Lett; 2005 Sep; 227(2):175-84. PubMed ID: 16112420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter analysis of epigenetically controlled genes in bladder cancer.
    Veerla S; Panagopoulos I; Jin Y; Lindgren D; Höglund M
    Genes Chromosomes Cancer; 2008 May; 47(5):368-78. PubMed ID: 18196590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.